Project Grant K23MH138758
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Boston Children's Hospital a $990,550 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective March 10, 2026, with completion targeted for February 29, 2028. This R61/R33 phased research award will develop and test a computer-based cognitive control and metacognition training intervention designed to reduce restricted and repetitive behaviors in school-aged children with autism...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $863,276 to the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) on February 3, 2026, to conduct a research study examining the effectiveness of the Resilience in Action (RIA) curriculum for young adults with autism spectrum disorder (AASD). The project, titled "Resilience in Action: Assessing the Behavioral Target Mechanisms of the RIA Curriculum in...
- Federal Grant Award Summary Children's Hospital Los Angeles received a $769.5K Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on March 15, 2026, through March 14, 2029. The award funds research on the feasibility, acceptability, and preliminary effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY) when delivered in clinical settings by clinicians with limited autism...
- Federal Grant Award Summary The National Institute of Mental Health awarded the University of Pittsburgh a $792,006 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study examining suicidality in autistic adults. Commencing September 1, 2025, and concluding June 30, 2030, this research initiative will enroll 250 autistic adults (ages 18-40), with at least half representing high-risk individuals with active suicidal ideation or suicidal...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $844,917 under the Mental Health Research Grants program (CFDA 93.242) with an award date of July 1, 2025, and completion date of April 30, 2026. This project, titled "Moderate Effect Size Genes in Autism Spectrum Disorder," funds research to identify and characterize genes with moderate effect sizes that contribute to autism spectrum...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Rochester a $174,381 Project Grant effective September 1, 2025, through August 31, 2029, under the Mental Health Research Grants program (CFDA 93.242). This award funds the development and testing of Cognitive Behavioral Therapy for Treatment-Seeking (CBT-TS) specifically adapted for deaf individuals, a historically understudied and underserved population experiencing elevated rates of suicidal...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Regents of the University of California, San Francisco a Project Grant of $458,177 under the Mental Health Research Grants program (CFDA 93.242) for the period June 9, 2025 through June 8, 2027. The research project, titled "Leveraging Population Level Data to Inform Prevention and Treatment of Adolescent Depression Following Social Adversities," addresses the significant gap between current...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Columbia University's Health Sciences Division a $180,360 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to design, test, and deploy a brief single-session intervention (SSI) for adolescents with depression. The project, which commenced on May 11, 2026, and extends through April 30, 2031, adapts Interpersonal Psychotherapy for Adolescents (IPT-A)—an evidence-based gold standard...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $394,200 to the Research Foundation For Mental Hygiene, Inc. (through its New York State Psychiatric Institute division) under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2025, for a five-year project period extending through July 31, 2030. This Project Grant funds a clinical research study examining the role of the anterior hippocampus in major depressive disorder (MDD) pathogenesis....
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Southern California a $817,597 Project Grant (CFDA 93.242 – Mental Health Research Grants) on September 19, 2025, to develop machine learning prediction models for identifying autistic children and youth at greatest risk for persistent adverse mental health outcomes. The primary deliverables include: (1) identification and extraction of social determinants of health (SDOH) factors from...
The National Institute of Mental Health (NIMH) awarded $195,046 to Stony Brook University through the Mental Health Research Grants program (CFDA 93.242) on May 25, 2026, to refine and test a behavioral activation (BA) treatment for depression in autistic adolescents. This project addresses a critical gap in mental health treatment, as autistic youth experience depression at significantly higher rates than neurotypical peers, yet no evidence-based interventions currently exist for this population. Building on preliminary pilot work demonstrating significant symptom improvement, the project will iteratively refine a previously developed BA treatment manual and materials through structured feedback from community stakeholders, including three focus groups with caregivers, three focus groups with mental health providers, and individual interviews with autistic adolescents aged 12-17 years experiencing depression. Following treatment refinement, the project will evaluate the efficacy of the refined BA intervention through an initial randomized controlled trial (RCT) involving 60 autistic adolescents, comparing the BA treatment against an enhanced treatment-as-usual control condition. The research will be conducted in partnership with a Community Advisory Board comprising autistic youth, caregivers, and autism-serving mental health providers to ensure the intervention aligns with community needs and values. The project period extends from May 2026 through April 2031, with deliverables including a refined, manualized BA treatment protocol and empirical data on treatment effectiveness from a rigorous controlled trial design.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $195.0k | 5/27/26 |